Crossmark

Effectiveness of anti-CGRP monoclonal antibodies in the preventive treatment of migraine: A prospective study of 63 patients

Crossref DOI link: https://doi.org/10.1016/j.medcle.2022.09.024

Published Print: 2023-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Castrillo, Ana

Mendoza, Amelia

Caballero, Lorena

Cerdán, Débora

Rodríguez, María Fernanda

Guerrero, Pilar

Tabernero, César

Ferrero, Marta

Benito, Inés

Marín, Laura

Duarte, Jacinto
License Information

Text and Data Mining valid from 2023-04-01

stm-asf valid from 2023-04-01

stm-asf valid from 2023-04-01

stm-asf valid from 2023-04-01

stm-asf valid from 2023-04-01

stm-asf valid from 2023-04-01
More Information

This article is maintained by: Elsevier

Article Title: Effectiveness of anti-CGRP monoclonal antibodies in the preventive treatment of migraine: A prospective study of 63 patients

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2022.09.024

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2022.09.023

Content Type: article

Copyright: © 2022 Elsevier España, S.L.U. All rights reserved.